These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The role of appendectomy for mucinous ovarian neoplasms. Lin JE; Seo S; Kushner DM; Rose SL Am J Obstet Gynecol; 2013 Jan; 208(1):46.e1-4. PubMed ID: 23117124 [TBL] [Abstract][Full Text] [Related]
28. Borderline epithelial tumors of the ovary. Hart WR Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675 [TBL] [Abstract][Full Text] [Related]
30. A case of ovarian mucinous adenocarcinoma in a premenarcheal girl. Matsushita Y; Yokoyama Y; Taniguchi R; Abe K; Watanabe J; Mizunuma H Int J Clin Oncol; 2012 Oct; 17(5):517-21. PubMed ID: 22016113 [TBL] [Abstract][Full Text] [Related]
31. Management of a primary retroperitoneal mucinous cystadenocarcinoma: case report. Kurita T; Nakajima K; Koi C; Matsuura Y; Hachisuga T Eur J Gynaecol Oncol; 2014; 35(2):163-6. PubMed ID: 24772920 [TBL] [Abstract][Full Text] [Related]
32. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy. Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911 [TBL] [Abstract][Full Text] [Related]
33. Osteosarcoma as Malignant Mural Nodule in Ovarian Mucinous Neoplasms of Intestinal Type: Report of 2 Cases. McFarland M; Dina R; Fisher C; McCluggage WG Int J Gynecol Pathol; 2015 Jul; 34(4):369-73. PubMed ID: 25760909 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum? Jordan SJ; Green AC; Whiteman DC; Webb PM; Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378 [TBL] [Abstract][Full Text] [Related]
35. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
36. Expression of REG4 in ovarian mucinous tumors. Huang Q; Chen X; Lu W; Lai M; Lu B Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547 [TBL] [Abstract][Full Text] [Related]
38. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376 [TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of grading in borderline mucinous tumors of the ovary. Sumithran E; Susil BJ; Looi LM Hum Pathol; 1988 Jan; 19(1):15-8. PubMed ID: 2826326 [TBL] [Abstract][Full Text] [Related]
40. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary. Virk R; Lu D Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]